Are there any drug interactions or safety concerns for a patient taking propranolol 40 mg daily together with lisdexamfetamine (Vyvanse) 70 mg daily, dexamfetamine 5 mg six times daily, olanzapine 2.5 mg nightly, and fluorometholone 0.1% eye drops?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Drug Interactions Between Propranolol and ADHD Stimulants

Yes, there is a clinically significant pharmacodynamic interaction between propranolol and amphetamine-based stimulants (lisdexamfetamine and dexamfetamine) that requires careful monitoring, though concurrent use is not absolutely contraindicated.

Primary Cardiovascular Interaction

The combination of propranolol with amphetamine stimulants creates opposing cardiovascular effects that can result in unopposed alpha-adrenergic stimulation and paradoxical hypertension. 1, 2, 3

  • Amphetamines (both lisdexamfetamine and dexamfetamine) increase dopamine and noradrenaline concentrations, promoting sympathetic stimulation with resultant increases in heart rate and blood pressure 1, 2
  • Propranolol blocks beta-adrenergic receptors, preventing the beta-mediated vasodilation that normally counterbalances alpha-mediated vasoconstriction 4
  • When beta-blockade is present, amphetamine-induced noradrenaline release can cause unopposed alpha-receptor stimulation, potentially leading to severe hypertension and reflex bradycardia 5

Specific Cardiovascular Monitoring Required

This patient requires regular blood pressure and heart rate monitoring given the extremely high stimulant burden (70 mg lisdexamfetamine PLUS 30 mg dexamfetamine daily = 100 mg total amphetamine equivalent). 5

  • Lisdexamfetamine 70 mg daily alone increases pulse by approximately 5.2 bpm on average 5
  • The additional 30 mg dexamfetamine (6 tablets × 5 mg) compounds cardiovascular effects 3, 6
  • Propranolol's beta-blockade may mask tachycardia but not prevent hypertensive episodes 4
  • Monitor for pulse outliers (≥100 bpm) and blood pressure elevations, which occurred in 3.3-8.5% of patients on lisdexamfetamine alone 5

Olanzapine Interaction Considerations

Olanzapine should be used with caution when combined with propranolol due to additive hypotensive effects and potential for excessive sedation. 7

  • Both propranolol and olanzapine can cause hypotension independently 4, 7
  • Olanzapine at 2.5 mg nightly is a low dose, reducing but not eliminating interaction risk 7
  • The NCCN guidelines note that olanzapine causes fatigue and drowsiness, which may be compounded by propranolol's CNS effects 7
  • Avoid excessive dopamine blockade by not adding metoclopramide, phenothiazines, or haloperidol to this regimen 7

Fluorometholone Eye Drops

No clinically significant systemic interaction exists between topical fluorometholone 0.1% eye drops and propranolol or the ADHD medications.

  • Topical ophthalmic corticosteroids have minimal systemic absorption
  • No documented interactions with beta-blockers or amphetamines in the provided evidence

Critical Clinical Monitoring Algorithm

Implement the following monitoring schedule for this high-risk medication combination:

  1. Baseline assessment: Blood pressure, heart rate, ECG if not done within past year 5
  2. Weekly monitoring for first month: Blood pressure and heart rate measurements 5
  3. Monthly monitoring thereafter: Blood pressure, heart rate, and assessment for cardiovascular symptoms 5
  4. Immediate evaluation if: Blood pressure >140/90 mmHg, pulse >100 bpm at rest, chest pain, palpitations, or severe headache 4, 5

Propranolol-Specific Adverse Effects to Monitor

Beyond cardiovascular interactions, monitor for propranolol's direct adverse effects that may be mistakenly attributed to other medications: 8, 9

  • Dizziness and fatigue (common with propranolol 40 mg daily) 8, 9
  • Sleep disturbances, nightmares, and nocturnal agitation (2-18.5% incidence) 9
  • Musculoskeletal aches and pain, particularly in legs and feet (dose-dependent) 9
  • Hypoglycemia risk, especially if fasting or with irregular meals 9
  • Bronchospasm (contraindicated in asthma; use extreme caution in COPD) 4, 9

Dose Optimization Strategy

If cardiovascular adverse effects occur, reduce propranolol to the smallest effective dose rather than discontinuing stimulants, given the patient's established ADHD treatment regimen. 8

  • Consider dividing propranolol 40 mg daily into 20 mg twice daily to avoid peak concentrations 8
  • Alternative: Switch to extended-release propranolol formulation for more stable plasma levels 8
  • If dizziness or hypotension persists, consider switching to cardioselective beta-blocker (metoprolol, bisoprolol, atenolol) which may cause fewer side effects 8

Absolute Contraindications for Continuing This Combination

Discontinue propranolol immediately if any of the following develop: 4

  • Severe bradycardia (heart rate <50 bpm with symptoms)
  • AV block greater than first degree
  • Decompensated heart failure
  • Cardiogenic shock
  • Severe hypotension (systolic BP <90 mmHg with symptoms)
  • Severe hypertension (systolic BP >180 mmHg or diastolic >110 mmHg)

Common Pitfall to Avoid

Do not assume new symptoms are solely due to stimulants—propranolol causes significant CNS effects including fatigue, sleep disturbances, and dizziness that may be incorrectly attributed to ADHD medications or psychiatric comorbidity. 9 The patient's olanzapine use suggests possible mood or psychotic symptoms, making it crucial to distinguish medication side effects from underlying psychiatric conditions.

Related Questions

For a male patient with ADHD taking 30 mg of Vyvanse (lisdexamfetamine) who experiences excess energy, can the dose be split into 20 mg in the morning and 10 mg in the afternoon?
How should resting tachycardia be managed in a 19‑year‑old male with attention‑deficit/hyperactivity disorder taking lisdexamfetamine (Vyvanse) 50 mg daily?
Is routine blood monitoring required for patients taking lisdexamfetamine (Elvanse)?
Can I prescribe Vyvanse (lisdexamfetamine) 20 mg in the afternoon at the patient’s request?
How can I safely transition a patient on Adderall (dextroamphetamine‑amphetamine) 5 mg once daily to Vyvanse (lisdexamfetamine), including appropriate initial dose, titration schedule, and necessary cardiovascular and psychiatric monitoring?
In adult patients with diabetes or peripheral arterial disease, how does the prognosis, functional outcome, and mortality of bilateral below‑knee amputation (BKA) compare to above‑knee amputation (AKA)?
How should opioid‑induced pruritus be managed in an adult patient receiving morphine, oxycodone, or hydromorphone for pain while preserving analgesia?
What is the minimum age to initiate cephalexin therapy in pediatric patients and the recommended weight‑based dosing schedule?
How should a pregnant woman with dysuria, frequency, urgency, suprapubic or flank pain be evaluated and treated for a urinary tract infection?
When is it appropriate to start inotropic therapy in a patient with low cardiac output and signs of end‑organ hypoperfusion (e.g., hypotension, cool extremities, oliguria, rising lactate, altered mental status, acidosis) despite adequate volume optimization?
What is the appropriate acute management for a patient presenting with presyncope and severe hyponatremia (serum sodium 115 mmol/L)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.